Vedolizumab use is not associated with increased malignancy incidence: GEMINI LTS study results and post-marketing data (Alimentary Pharmacology and Therapeutics, 2019)

(untitled) - Card, T; Ungaro, R; Bhayat, F; Blake, A; Hantsbarger, G; Travis, S